🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Louis Moore Bacon’s MBX Holdings & Trades

First Buy
Q2 2026
Duration Held
2 Quarters
Largest Add
Q2 2026
+64,893 Shares
Current Position
59,160 Shares
$3.47 M Value

Louis Moore Bacon's MBX Position Overview

Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 59,160 shares of MBX Biosciences, Inc. (MBX) worth $3.47 M, representing 0.07% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Louis Moore Bacon has initiated a new position in MBX, representing a fresh investment thesis on this company. Largest reduction occurred in Q3 2026, reducing 5,733 shares.

Analysis based on 13F filings available since 2013 Q2

Louis Moore Bacon's MBX Biosciences (MBX) Holding Value Over Time

Track share changes against reported price movement

Quarterly MBX Biosciences (MBX) Trades by Louis Moore Bacon

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 -5,733 Reduce 8.83% 59,160 $58.62
Q2 2026 +64,893 New Buy 64,893 $55.20

Louis Moore Bacon's MBX Biosciences Investment FAQs

Louis Moore Bacon first purchased MBX Biosciences, Inc. (MBX) in Q2 2026, acquiring 64,893 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Louis Moore Bacon has held MBX Biosciences, Inc. (MBX) for 2 quarters since Q2 2026.

Louis Moore Bacon's largest addition to MBX Biosciences, Inc. (MBX) was in Q2 2026, adding 64,893 shares worth $3.58 M.

According to the latest 13F filing for Q3 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 59,160 shares of MBX Biosciences, Inc. (MBX), valued at approximately $3.47 M.

As of the Q3 2026 filing, MBX Biosciences, Inc. (MBX) represents approximately 0.07% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.

Louis Moore Bacon's peak holding in MBX Biosciences, Inc. (MBX) was 64,893 shares, as reported at the end of Q2 2026.